Chemotherapy and Radiation
710 articles
COVID-19—An Update
What is the status of international and US travel? Which states have mask mandates? Are vaccines progressing? Read our COVID-19 update for more information.
CRISPR: A New Tool to Help Understand Cancer-Linked Mutations
Lukas Dow, Ph.D., is using CRISPR technology to find better ways to fight cancer by editing the genome.
Study Reveals Molecular Differences in Young-Onset Pancreatic Cancer
There has been a notable increase in cases of young onset pancreatic cancer. Dr. Jashodeep Datta and team are exploring why this is happening.
Pancreatic Cancer Exceptional Responders and the Immune System Link
Dr. Vinod Balachandran looks at the immune system of exceptional responders–patients who respond extremely well to chemotherapy–for treatment clues.
Symptoms
Learn about the symptoms of pancreatic cancer. The symptoms of pancreatic cancer are similar to the symptoms for many other illnesses. This makes it hard to recognize and diagnose the disease at earlier, more treatable stages. What are the symptoms of pancreatic cancer? Adenocarcinoma Neuroendocrine Main Symptoms of Adenocarcinoma (or Exocrine) Tail Head Body Tail […]
About Us
Let’s Win is your guide to hope and action. Our mission is to guide patients with vital information for better outcomes. We envision a world where all patients have access to the best treatment options. Let’s Win is a go-to guide with easy-to-understand, medically vetted and actionable content focused on the needs of the patient […]
What You Should Know About Pancreatic Cysts
Dr. V. Raman Muthusamy explains the difference between pancreatic cysts and pancreatic cancer. Learn about different types of pancreatic cysts and which may develop cancer.
Treatments and the Importance of Clinical Trials
In a webinar, Drs. Allyson Ocean and Arturo Loaiza-Bonilla discuss pancreatic cancer treatments and why clinical trials are so important.
Let’s Learn About Pancreatic Cancer
Let’s Win and the National Alliance for Hispanic Health’s Nuestras Voces program held their first webinar in Spanish.